NirvaMed Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Series A3

  • Investors
  • 6

NirvaMed General Information

Description

Developer of a patented breakthrough therapy designed to reduce heart muscle damage suffered by heart attack patients. The company's system provides treatment for myocardial infarction attacks through its proprietary percutaneous catheter, which substantially reduces muscle death and redefines the standard of care, enabling medical professionals to reduce health disparity in communities.

Contact Information

Formerly Known As
Nirva Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8500 Pillsbury Avenue South
  • Minneapolis, MN 55420
  • United States
+1 (952)
Primary Industry
Therapeutic Devices
Vertical(s)
Corporate Office
  • 8500 Pillsbury Avenue South
  • Minneapolis, MN 55420
  • United States
+1 (952)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NirvaMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A3) 01-Mar-2023 Completed Generating Revenue
3. Later Stage VC (Series B) 11-Jun-2021 Cancelled Generating Revenue
2. Later Stage VC (Series A2) 07-Sep-2019 $4.88M $5.13M Completed Generating Revenue
1. Angel (individual) 20-Apr-2015 $260K $260K Completed Generating Revenue
To view NirvaMed’s complete valuation and funding history, request access »

NirvaMed Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a patented breakthrough therapy designed to reduce heart muscle damage suffered by heart attack patients. T
Therapeutic Devices
Minneapolis, MN
4 As of 2024

Mullica Hill, NJ
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NirvaMed Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
FocalCool Corporation Mullica Hill, NJ
You’re viewing 1 of 1 competitors. Get the full list »

NirvaMed Patents

NirvaMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11173239-B2 Localized therapy delivery and local organ protection Active 02-Feb-2010
US-20190275231-A1 Localized therapy delivery and local organ protection Active 02-Feb-2010
US-20160175513-A1 Localized therapy delivery and local organ protection Active 02-Feb-2010
US-10195333-B2 Localized therapy delivery and local organ protection Active 02-Feb-2010
US-9308310-B2 Localized therapy delivery and local organ protection Active 02-Feb-2010 A61M1/3613
To view NirvaMed’s complete patent history, request access »

NirvaMed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NirvaMed Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bangkok Dusit Medical Services Corporation Minority
GC Ventures Corporate Venture Capital Minority
PTT Global Chemical Corporation Minority
Samart Corp Corporation Minority
SeaX Ventures Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

NirvaMed FAQs

  • When was NirvaMed founded?

    NirvaMed was founded in 2010.

  • Where is NirvaMed headquartered?

    NirvaMed is headquartered in Minneapolis, MN.

  • What is the size of NirvaMed?

    NirvaMed has 4 total employees.

  • What industry is NirvaMed in?

    NirvaMed’s primary industry is Therapeutic Devices.

  • Is NirvaMed a private or public company?

    NirvaMed is a Private company.

  • What is NirvaMed’s current revenue?

    The current revenue for NirvaMed is .

  • How much funding has NirvaMed raised over time?

    NirvaMed has raised $5.13M.

  • Who are NirvaMed’s investors?

    Bangkok Dusit Medical Services, GC Ventures, PTT Global Chemical, Samart Corp, and SeaX Ventures are 5 of 6 investors who have invested in NirvaMed.

  • Who are NirvaMed’s competitors?

    FocalCool is a competitor of NirvaMed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »